Author Page for Sherene Loi

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Baseline Tumour Burden and Prognosis in Breast Cancer Treated with Immune Checkpoint Inhibitors

Number of pages: 17 Posted: 31 Mar 2025

Julia Robyn Dixon-Douglas, Lauren C. Brown, Kate Moodie, Courtney T. Van Geelen, Steven David, Prudence A. Francis, Peter Savas and Sherene Loi

Peter MacCallum Cancer Centre, Peter MacCallum Cancer Centre, Peter MacCallum Cancer Centre, Peter MacCallum Cancer Centre, Monash Health, Peter MacCallum Cancer Centre, Peter MacCallum Cancer Centre and University of Melbourne

Downloads 31 (1,304,549)

Abstract:

Identifying Premenopausal Patients with Early-Stage Hormone Receptor–Positive Breast Cancer at Minimal Risk of Distant Recurrence by Breast Cancer Index

Number of pages: 20 Posted: 12 Dec 2025

Ruth M. O’Regan, Yue Ren, Yi Zhang, Gini F. Fleming, Prudence A. Francis, Olivia Pagani, Barbara A. Walley, Roswitha Kammler, Patrizia Dell’Orto, Guiseppe Viale, Sherene Loi, Marco Colleoni, Kai Treuner and Meredith M. Regan

University of Rochester, Harvard University - Dana-Farber Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Peter MacCallum Cancer Centre, University of Geneva - Geneva University Hospitals, University of Calgary, affiliation not provided to SSRN, affiliation not provided to SSRN, European Institute of Oncology (IEO) IRCCS, University of Melbourne, European Institute of Oncology (IEO) - Division of Medical Senology, affiliation not provided to SSRN and Harvard University - Dana-Farber Cancer Institute

Downloads 18 (1,470,786)

Sherene Loi

University of Melbourne

2

49

0

Scholarly Papers (2)

Baseline Tumour Burden and Prognosis in Breast Cancer Treated with Immune Checkpoint Inhibitors

Abstract:

Identifying Premenopausal Patients with Early-Stage Hormone Receptor–Positive Breast Cancer at Minimal Risk of Distant Recurrence by Breast Cancer Index

Abstract: